| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |